Icons.Health is coaxing bright ideas out of health care industry thought leaders
It began with Massachusetts Institute of Technology (MIT) “hackathons” and a billion-dollar inspiration.
Featured Posts
Pharma Innovators Special Feature 2018: Focus on innovation
In seeking innovative players that could change pharma and healthcare, Med Ad News found the developer of an app that helps people determine what illnesses are in their neighborhoods; the creator of a wearable injector that allows patients on biologics to receive these drugs outside the clinic; and a designer of a deep learning network aimed at giving pharma and healthcare companies a handle on their data.
AR/VR Special Feature 2018: The agency perspective
Med Ad News spoke with Gene Fitzpatrick, senior VP of engagement strategy for Ogilvy CommonHealth Worldwide, about the future of augmented and virtual reality in healthcare marketing.
AR/VR Special Feature 2018: Beyond the hype – AR and VR in healthcare
Augmented reality (AR) and virtual reality (VR) have experienced incredible growth since 2013, when the first Oculus Rift VR headset hit the market and provided a whole new sense of what was possible.
Special Feature: Mobile in the hospital
As private practices close and the number of doctors joining rep-restricted hospital-based and integrated delivery networks of healthcare increases, pharma needs to look at the advantages of mobile marketing to “detail” these hospital-based professionals.
MIT Researchers Discover CRISPR Enzyme That Can Target Almost Half of Genome Locations
Researchers at the Massachusetts Institute of Technology (MIT) published research in the journal Science Advances describing yet another CRISPR improvement.
Synthego Snags $110 Million in Series C to Advance Vision of Making CRISPR Technology More Available
Genome engineering company Synthego received an infusion of $110 million from a Series C financing round led by Peter Thiel’s Founders Fund. The funds will be used to accelerate the company’s vision to make CRISPR technology more accessible to researchers.
Hip and knee surgeons to use Apple Watch to monitor patients
Up to 10,000 Americans due to have hip or knee replacements will be able to funnel basic health data directly from their Apple Watches to their surgeons under a new app being tested by prosthetic limb specialist Zimmer Biomet.
FDA Lifts Clinical Hold; Green-Lights Vertex and CRISPR’s Sickle Cell Gene Therapy Trial
The U.S. Food and Drug Administration lifted a clinical hold and accepted an Investigational New Drug Application (IND) for an experimental sickle cell disease treatment being jointly developed by Vertex Pharmaceuticals and CRISPR Therapeutics.
Can AI Detect Parkinson’s Disease from a Video? Tencent and Medopad Team up to Find Out
Medopad, a U.K.-based medical firm, and China-based Tencent Holdings have teamed up on a project that will attempt to harness artificial intelligence in the diagnosis of Parkinson’s disease.
Johnson & Johnson Vision Launches Worldwide Campaign to #SpotlightSight in Honor of World Sight Day
Johnson & Johnson Vision, a broad-based global leader in eye health, launched a worldwide campaign to #spotlightsight in honor of World Sight Day on October 11, 2018.
Trio wins chemistry Nobel for work on antibody drugs, smart enzymes
Two Americans and a Briton won the 2018 Nobel Prize for Chemistry for harnessing the power of evolution to generate novel proteins.
Promising Early-Stage Results for Novel Malaria Therapeutics
Two antimalarial strategies have been published from Imperial College London: new compounds that prevent the malaria parasite from infecting mosquitoes and gene-edited mosquitoes that cannot reproduce, leading to population destruction.
One Drop’s Apple Watch App Points to Trend in Wearable Health Devices
Personalized medicine continues to grow in importance, and having the ability to monitor health data has proven to be a significant desire for people as the number of wearable devices continues to grow.
Klick Health’s Incubated Startup, Circulation, Announces Successful Exit
Klick Health’s growing commercialization partner portfolio is proud of the successful exit of Circulation, one of Klick’s first incubation initiatives.
The Voice Revolution in Healthcare
Voice search (such as Apple Siri) and voice assistants (such as Amazon ECHO “Alexa”) are on the rise, and it’s been predicted that by the end of 2020, 50% of interactions with technology will be via “conversations” with them.
AstraZeneca plots China robot offensive to counter price cuts
With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca aims to move from simply supplying drugs to become a broad healthcare provider in China.
Medtech Company Endotronix Snags $45 Million in Series D Funding
Lisle, Ill.-based medtech company Endotronix Inc. secured $45 million in a Series D financing round.
HBA Global Presents Two Webinars – Improving Your Communication and Presentation Skills
HBA is hosting two educational webinars in October 2018: “Increase Your Communication Confidence in Three Weeks: There’s an APP for That” and “Presenting Effectively in Any Situation”
One in three U.S. teens text while driving, survey shows
One in three teen drivers in the U.S. text while driving, new survey data suggests, and the number may be higher in states where teens start driving at younger ages.
Researchers Use CRISPR to Treat Duchenne Muscular Dystrophy in Dogs
Researchers at the University of Texas Southwestern Medical Center used CRISPR gene editing to treat Duchenne muscular dystrophy (DMD) in dogs. Their work was published in the journal Science.
Computer Program Can Predict How Cancer Tumors Will Respond to Drugs Before Dosing Begins
A new computer tool has been developed to predict how some cancers may respond to an investigational treatment before the drug has even been administered to a patient.
Interference Proceedings Relating to CRISPR/Cas9 Genome Editing Technology Patents
Intellia Therapeutics will host an educational briefing webinar on interference proceedings relating to CRISPR/Cas9 genome editing technology patents.
FDA Clears SPR Therapeutics’ Non-Opioid Neurostimulation Pain Therapies
The U.S. Food and Drug Administration cleared Cleveland-based SPR Therapeutics’ SPRING endura (single lead) and extensa (dual lead) Peripheral Nerve Stimulation Systems for controlling pain.
Ad Right Top
MedAdNews
Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.
October 2018 Focus: Top 50 Pharma, Company of the Year and more!